Edgewise Therapeutics
EWTX
EWTX
176 hedge funds and large institutions have $2.7B invested in Edgewise Therapeutics in 2024 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 58 increasing their positions, 44 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
32% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 44
26% more funds holding
Funds holding: 140 → 176 (+36)
0.74% less ownership
Funds ownership: 108.8% → 108.06% (-0.74%)
Holders
176
Holding in Top 10
8
Calls
$60M
Puts
$13.3M
Top Buyers
| 1 | +$52.3M | |
| 2 | +$52.1M | |
| 3 | +$26.7M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$24.4M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$18.5M |
Top Sellers
| 1 | -$110M | |
| 2 | -$48.3M | |
| 3 | -$30.4M | |
| 4 |
DM
Deerfield Management
New York
|
-$29.2M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$24M |